Lucid Diagnostics Inc. a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc., announced that its Chairman and Chief Executive Officer, Lishan Aklog, M.D., highlighted Lucid’s EsoCheck® Cell Collection Device during testimony before the U.S. House of Representatives’ Committee on Small Business.
